The prevalence of CRC has driven efforts by experts and physicians to expand access to CRC screening to ensure that cases are caught as early as possible.
More than 15 years ago, Michael Potter, MD, a professor of family community medicine at the University of California San Francisco, began working with community health clinics to offer take-home fecal immunochemical tests alongside regular flu vaccines, according to a Sept. 30 UCSF news release. Patients who opt into the tests collect samples at home before sending them to a lab for testing.
Community health centers in all 50 states now use this model, dubbed FluFIT.
Dr. Potter still emphasizes the importance of getting a follow-up colonoscopy if the FIT test produces abnormal results. He also notes that for those with a family history of CRC, screening before the recommended age 45 can be important.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
